Incidence, clinical course, and risk factors in the development of femoral pseudoaneurysm after atrial fibrillation ablation

被引:0
|
作者
Koyama, Takafumi [1 ]
Tobita, Kazuki [1 ]
Kawaguchi, Tatsuto [1 ]
Uchida, Shuhei [1 ]
Koyama, Eiji [1 ]
Kodera, Nobuhisa [1 ]
Tamaki, Yusuke [1 ]
Otomaru, Yuri [1 ]
Miyashita, Hirokazu [1 ]
Yamashita, Takayoshi [1 ]
Mizuno, Shingo [1 ]
Murakami, Masato [1 ]
Saito, Shigeru [1 ]
机构
[1] Shonan Kamakura Gen Hosp, Dept Cardiol, 1370-1 Okamoto, Kamakura, Kanagawa 2470072, Japan
关键词
aneurysm false*/etiology; atrial fibrillation; catheter ablation/adverse effects*; thrombin*; CATHETER ABLATION; REPAIR;
D O I
10.1002/joa3.12950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrevious studies have revealed the risk factors for femoral pseudoaneurysms (FPA). Most data on FPA are based on coronary and peripheral interventions, with limited studies focusing on atrial fibrillation (AF) ablation. However, patient backgrounds, anticoagulation regimens, and vascular access methods differ. In addition, a standard for managing FPA after AF ablation remains elusive due to the difficult nature of achieving thrombosis in pseudoaneurysms.MethodsThis single-center, retrospective, observational study included 2805 consecutive patients who underwent AF ablation between January 2016 and December 2021. All patients underwent femoral artery and vein punctures. Puncture sites were checked 1 day post-procedure.ResultsA total of 23 FPA patients were identified during the study period. Multivariate logistic regression analysis showed that hypertension (odds ratio 4.66, 95% confidence interval: 1.38-15.71; p = .0032) and warfarin use (odds ratio 3.83, 95% confidence interval: 1.40-10.45; p = .021) were significantly associated with the occurrence of FPA. The compression success rate was low (22%). There were nine and six patients in the endovascular treatment (EVT) and ultrasound-guided thrombin injection (UGTI) groups, respectively. The success rates were 100% and 84% in the EVT and UGTI groups, respectively. The length of hospital stay after FPA treatment was 2.1 days in the EVT group and 1.3 days in the thrombin group.ConclusionWe must be careful about post-procedural FPA, especially for hypertension and warfarin-using patients. Treatment of pseudoaneurysms with anticoagulants is unlikely to achieve hemostasis, and an early switch to invasive treatments, such as EVT, should be considered. In our investigation of atrial fibrillation ablation, we identified warfarin and hypertension as primary risk factors for femoral pseudoaneurysms. Our findings indicated that endovascular balloon inflation and thrombin injection were effective, with minimal complications and shortened hospital stays.image
引用
收藏
页码:894 / 900
页数:7
相关论文
共 50 条
  • [1] Acute pericarditis after atrial fibrillation ablation: Incidence, characteristics, and risk factors
    Nakhla, Shady
    Mentias, Amgad
    Rymer, Christopher
    Hussein, Ayman
    Wazni, Oussama
    Rickard, John
    Baranowski, Bryan
    Cantillon, Daniel
    Klein, Allan L.
    Cremer, Paul C.
    Taigen, Tyler L.
    HEART RHYTHM O2, 2022, 3 (03): : 248 - 251
  • [2] Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter
    Huang, Henry D.
    Waks, Jonathan W.
    Contreras-Valdes, Fernando M.
    Haffajee, Charles
    Buxton, Alfred E.
    Josephson, Mark E.
    EUROPACE, 2016, 18 (04): : 521 - 530
  • [3] Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter
    Valérie Laurent
    Laurent Fauchier
    Bertrand Pierre
    Caroline Grimard
    Dominique Babuty
    Journal of Interventional Cardiac Electrophysiology, 2009, 24 : 119 - 125
  • [4] Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter
    Laurent, Valerie
    Fauchier, Laurent
    Pierre, Bertrand
    Grimard, Caroline
    Babuty, Dominique
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2009, 24 (02) : 119 - 125
  • [5] Incidence, Risk Factors, and Clinical Outcomes of Atrial Fibrillation and Atrial Flutter After Heart Transplantation
    Dasari, Tarun W.
    Pavlovic-Surjancev, Biljana
    Patel, Nilamkumar
    Williams, Alexis A.
    Ezidinma, Phoebe
    Rupani, Arti
    Sinacore, James L.
    Heroux, Alain L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (05): : 737 - 741
  • [6] Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation
    Sotomi, Yohei
    Inoue, Koichi
    Ito, Norihisa
    Kimura, Ryusuke
    Toyoshima, Yuko
    Masuda, Masaharu
    Iwakura, Katsuomi
    Fujii, Kenshi
    EUROPACE, 2013, 15 (11): : 1581 - 1586
  • [7] Incidence and risk factors of post-operative cognitive decline after ablation for atrial fibrillation
    Jing Zhang
    Shi-Jun Xia
    Xin Du
    Chao Jiang
    Yi-Wei Lai
    Yu-Feng Wang
    Zhao-Xu Jia
    Liu He
    Ri-Bo Tang
    Jian-Zeng Dong
    Chang-Sheng Ma
    BMC Cardiovascular Disorders, 21
  • [8] Incidence and risk factors of post-operative cognitive decline after ablation for atrial fibrillation
    Zhang, Jing
    Xia, Shi-Jun
    Du, Xin
    Jiang, Chao
    Lai, Yi-Wei
    Wang, Yu-Feng
    Jia, Zhao-Xu
    He, Liu
    Tang, Ri-Bo
    Dong, Jian-Zeng
    Ma, Chang-Sheng
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [9] Predictors of atrial fibrillation recurrence after pulmonary vein ablation: Clinical and risk factors
    Castro-Garcia, J. M.
    Arenas-Jimenez, J. J.
    Adarve-Castro, A.
    Trigueros-Buil, H.
    Garfias-Baladron, M. J.
    Urena-Vacas, A.
    RADIOLOGIA, 2025, 67 (01): : 17 - 27
  • [10] Risk factors for venous bleeding complication at the femoral puncture site after catheter ablation of atrial fibrillation
    Arai, Hirofumi
    Mizukami, Akira
    Hanyu, Yoshihiro
    Kawakami, Takuya
    Shimizu, Yuki
    Hiroki, Jiro
    Yoshioka, Kenji
    Otani, Hirofumi
    Kuroda, Shunsuke
    Iwatsuka, Ryota
    Ueshima, Daisuke
    Hayashi, Tatsuya
    Matsumura, Akihiko
    Goya, Masahiko
    Sasano, Tetsuo
    JOURNAL OF ARRHYTHMIA, 2020, 36 (04) : 678 - 684